Kura Oncology’s $125 Million Financing Agreement

Laura Testa
Tagged:

Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction.Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now